What information must be maintained for each drug repackaged by a contract pharmacy?

The requirement to maintain the name and address of the prescriber for each drug repackaged by a contract pharmacy is important for several reasons. First, it ensures proper tracking and accountability in the dispensing processes, which is crucial in monitoring patient safety and ensuring the correct medication is administered. Having the prescriber’s information allows for enhanced communication, which can be essential if any issues arise with the repackaged medication, such as adverse reactions or drug interactions.

Additionally, maintaining such information supports compliance with regulatory and legal requirements. Pharmacists need to verify that medications dispensed are correctly authorized by prescribers and are suitable for the patients receiving them. This record-keeping is vital not only for operational efficiency but also for patient record management and continuity of care.

In contrast, other options such as maintaining a patient's social security number or clinical trial number are not standard requirements for drug repackaging records. Such information may not be directly related to the prescription and could raise privacy concerns, making them less relevant to the mandatory documentation needed in this context. Keeping track of the cost of the medication, while potentially useful for inventory and payment purposes, does not directly support the main clinical and legal responsibilities associated with repackaging decisions.